Compulsory Licensing in Russia in the view of COVID-19

Published date22 April 2020
Subject MatterMedical Research,Clinical Trials,Supreme Court of the Russian Federation,Patents,Compulsory Licenses,Pharmaceutical Patents,Public Health,Coronavirus/COVID-19,Pharmaceutical Industry,Intellectual Property Protection,Public Safety,Russia
AuthorDarina Lysachkina
Law FirmInternational Lawyers Network

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT